We are live on ! Find out more
SRTA

Strata Critical Medical Inc

126 hedge funds and large institutions have $179M invested in Strata Critical Medical Inc in 2025 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 46 increasing their positions, 30 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more capital invested

Capital invested by funds: $117M → $179M (+$62.5M)

53% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 30

45% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 20

7% more funds holding

Funds holding: 118126 (+8)

1.55% more ownership

Funds ownership: 53.33%54.88% (+1.6%)

66% less call options, than puts

Call options by funds: $1.51M | Put options by funds: $4.47M

Holders
126
Holders Change
+8
Holders Change %
+6.78%
% of All Funds
1.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
29
Increased
46
Reduced
30
Closed
20
Calls
$1.51M
Puts
$4.47M
Net Calls
-$2.96M
Net Calls Change
-$3.02M
Name Holding Trade Value Shares
Change
Change in
Stake
AllianceBernstein
51
AllianceBernstein
Tennessee
$298K +$73.1K +22,470 +44%
Invesco
52
Invesco
Georgia
$296K -$58.7K -18,037 -20%
AG
53
Algert Global
California
$284K +$29.4K +9,040 +15%
Wells Fargo
54
Wells Fargo
California
$261K +$96.1K +29,538 +84%
BCM
55
Bridgeway Capital Management
Texas
$231K
Millennium Management
56
Millennium Management
New York
$224K +$44.4K +13,635 +33%
SS
57
SBI Securities
Japan
$218K +$8.05K +2,472 +5%
ECM
58
ExodusPoint Capital Management
New York
$205K +$165K +50,817 New
XT
59
XTX Topco
Cayman Islands
$196K +$158K +48,684 New
Simplex Trading
60
Simplex Trading
Illinois
$187K +$88.9K +27,307 +143%
Jane Street
61
Jane Street
New York
$175K -$314K -96,364 -69%
CIS
62
Connors Investor Services
Pennsylvania
$149K +$120K +37,000 New
Stifel Financial
63
Stifel Financial
Missouri
$146K -$11.4K -3,516 -9%
Mirae Asset Global ETFs Holdings
64
Mirae Asset Global ETFs Holdings
Hong Kong
$141K +$1.12K +345 +1%
HSBC Holdings
65
HSBC Holdings
United Kingdom
$140K -$1.93K -592 -2%
T. Rowe Price Associates
66
T. Rowe Price Associates
Maryland
$122K +$17.4K +5,342 +22%
AL
67
Arnhold LLC
New York
$121K +$97.6K +30,000 New
BHCM
68
Brevan Howard Capital Management
Jersey
$120K +$97.2K +29,877 New
Verition Fund Management
69
Verition Fund Management
Connecticut
$116K +$94K +28,884 New
IIM
70
INTECH Investment Management
Florida
$115K -$42.5K -13,069 -31%
Citigroup
71
Citigroup
New York
$103K -$49.5K -15,199 -37%
Manulife (Manufacturers Life Insurance)
72
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$93.1K +$5.51K +1,693 +8%
VF
73
Virtu Financial
New York
$86K +$69.2K +21,263 New
New York State Common Retirement Fund
74
New York State Common Retirement Fund
New York
$85.5K
Deutsche Bank
75
Deutsche Bank
Germany
$78.7K -$36.6K -11,254 -37%

SRTA Hedge Fund Activity: Q2 2025 in Review

126 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc (SRTA) for Q2 2025, worth a combined $179M — up 54% from $117M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new SRTA positions and 20 closed out — a net gain of 9 holders — while 46 added to existing stakes and 30 trimmed.

The largest buyer was Prelude Capital Management, opening a new position worth an estimated $2.9M. The largest seller was JP Morgan Chase, cutting an estimated $1.3M.

  • 126 institutional investors held Strata Critical Medical Inc (SRTA) as of Q2 2025, up from 118 in Q1 2025.
  • Funds reported $179M of Strata Critical Medical Inc stock for Q2 2025, up 54% quarter-over-quarter.
  • 29 funds opened new Strata Critical Medical Inc positions in Q2 2025 and 20 closed out, a net change of +9 holders.
  • The largest Strata Critical Medical Inc buyer in Q2 2025 was Prelude Capital Management, an estimated $2.9M added.
  • The largest Strata Critical Medical Inc seller in Q2 2025 was JP Morgan Chase, an estimated $1.3M sold.

Based on aggregated 13F filings for Q2 2025.